US Biotech Share Sales Deliver Biggest First Week Since 2021

Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology ...
Blockonomi

Cathie Wood Sells Meta and Illumina, Loads Up on Early-Stage Genomics Stocks

ARK Invest bought $15.88M in GeneDx stock and sold $12.7M in Meta shares. Cathie Wood shifts portfolio from tech giants to ...

cathie wood’s ARK stock trades highlight intellia, personalis buys

Another significant acquisition was 262,769 shares of Personalisis Inc (NASDAQ:PSNL) through the ARKG ETF, valued at $2,251,930. This continues ARK’s trend of increasing its stake in Personalisis, ...
24/7 Wall St.

Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned

Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...
Zacks Investment Research on MSN

Here's why biotech ETFs are rallying hard

Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based ...
Blockonomi

Cathie Wood ARK Buys $13 Million Roblox Stock, Sells Meta Platforms

Cathie Wood's ARK bought $13.7M Roblox stock and sold $12.7M Meta stock Jan 6, 2026. Full breakdown of ARK ETF trades and ...